Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation-Reference-Cited by-同舟云学术

Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation

Published:1984-08-06 Issue:2 Volume:173 Page:287-290
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:

Author:

Gut J.,Gasser R.,Dayer P.,Kronbach T.,Catin T.,Meyer U.A.

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/0014-5793(84)80792-9/fullpdf

Reference20 articles.

1. POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN

2. Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

3. The genetic controlof bufuralol metabolisminman

4. Defective Oxidation of Drugs

5. The Upjohn Award Lecture 1981/La Conférence Upjohn 1981: The metabolism of xenobiotics in different populations

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient synthesis of chiral benzofuryl β-amino alcohols via a catalytic asymmetric Henry reaction;Organic & Biomolecular Chemistry;2017

2. Computational predictions of the site of metabolism of cytochrome P450 2D6 substrates: comparative analysis, molecular docking, bioactivation and toxicological implications;Drug Metabolism Reviews;2015-05-29

3. Mechanisms of Toxicity;Reference Module in Biomedical Sciences;2014

4. Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development;Current Medicinal Chemistry;2009-11-01

5. Substrate Specificity, Inhibitors and Regulation of Human Cytochrome P450 2D6 and Implications in Drug Development;Current Medicinal Chemistry;2009-07-01